217 related articles for article (PubMed ID: 30298593)
1. Self-expandable sirolimus-eluting stents compared to second-generation drug-eluting stents for the treatment of the left main: A propensity score analysis from the SPARTA and the FAILS-2 registries.
Montefusco A; D'Ascenzo F; Gili S; Smolka G; Chieffo A; Baumbach A; Escaned J; Sganzerla P; Tomassini F; Secco GG; Ugo F; Tamburino C; Nicolino A; Mancone M; Poli A; Yew KL; Cirillo P; Wanha W; Pastormerlo LE; di Summa R; Sardella G; Colombo A; Gaita F; Cortese B
Catheter Cardiovasc Interv; 2019 Feb; 93(2):208-215. PubMed ID: 30298593
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of polymer-free biolimus-eluting stents versus ultrathin stents in unprotected left main or coronary bifurcation: A propensity score analysis from the RAIN and CHANCE registries.
D'Ascenzo F; Gaido L; Bernardi A; Saglietto A; Franzé A; Ielasi A; Trabattoni D; Di Biasi M; Infantino V; Rognoni A; Helft G; Gangor A; Latini RA; De Luca L; Mitomo S; Ugo F; Smolka G; Huczek Z; Cortese B; Capodanno D; Chieffo A; Piazza F; di Mario C; Poli A; D'Urbano M; Romeo F; Giammaria M; Varbella F; Sheiban I; Escaned J; De Ferrari GM
Catheter Cardiovasc Interv; 2020 Feb; 95(3):522-529. PubMed ID: 31385427
[TBL] [Abstract][Full Text] [Related]
3. Propensity score matched all comers population treated with ultra-thin strut bare metal and sirolimus-probucol coated drug-eluting stents of identical stent architecture.
Krackhardt F; Rosli MA; Leschke M; Schneider A; Sperling C; Heang TM; Pons M; Sousa PJ; Kherad B; Waliszewski M
Catheter Cardiovasc Interv; 2018 Jun; 91(7):1221-1228. PubMed ID: 28944613
[TBL] [Abstract][Full Text] [Related]
4. Unselected Use of Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent for Coronary Revascularization.
Yamaji K; Zanchin T; Zanchin C; Stortecky S; Koskinas KC; Hunziker L; Praz F; Blöchlinger S; Moro C; Moschovitis A; Seiler C; Valgimigli M; Billinger M; Pilgrim T; Heg D; Windecker S; Räber L
Circ Cardiovasc Interv; 2018 Sep; 11(9):e006741. PubMed ID: 30354590
[TBL] [Abstract][Full Text] [Related]
5. Comparison between sirolimus- and paclitaxel-eluting stents for the treatment of older patients affected by coronary artery disease: results from a single-center allcomers registry.
Buja P; Lanzellotti D; Isabella G; Napodano M; Panfili M; Favaretto E; Iliceto S; Tarantini G
Heart Vessels; 2012 Nov; 27(6):553-8. PubMed ID: 21989862
[TBL] [Abstract][Full Text] [Related]
6. Comparison of 5-year outcomes in patients with and without unprotected left main coronary artery disease after treatment with sirolimus-eluting stents: insights from the j-Cypher registry.
Toyofuku M; Kimura T; Morimoto T; Hayashi Y; Shiode N; Nishikawa H; Nakao K; Shirota K; Kawai K; Hiasa Y; Kadota K; Nozaki Y; Isshiki T; Sone T; Mitsudo K;
JACC Cardiovasc Interv; 2013 Jul; 6(7):654-63. PubMed ID: 23866178
[TBL] [Abstract][Full Text] [Related]
7. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.
Serruys PW; Farooq V; Kalesan B; de Vries T; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Wijns W; Morice MC; Di Mario C; Corti R; Antoni D; Sohn HY; Eerdmans P; Rademaker-Havinga T; van Es GA; Meier B; Jüni P; Windecker S
JACC Cardiovasc Interv; 2013 Aug; 6(8):777-89. PubMed ID: 23968698
[TBL] [Abstract][Full Text] [Related]
8. Ten-Year Clinical Outcomes From a Trial of Three Limus-Eluting Stents With Different Polymer Coatings in Patients With Coronary Artery Disease.
Kufner S; Joner M; Thannheimer A; Hoppmann P; Ibrahim T; Mayer K; Cassese S; Laugwitz KL; Schunkert H; Kastrati A; Byrne RA;
Circulation; 2019 Jan; 139(3):325-333. PubMed ID: 30586724
[TBL] [Abstract][Full Text] [Related]
9. Six-year clinical outcomes of first-generation drug-eluting stents: a propensity-matched analysis.
Tarantini G; Barioli A; Facchin M; Frigo AC; Napodano M; Buja P; D'Amico G; Iliceto S; Isabella G
Coron Artery Dis; 2013 Aug; 24(5):440-8. PubMed ID: 23695366
[TBL] [Abstract][Full Text] [Related]
10. Three-year efficacy and safety of new- versus early-generation drug-eluting stents for unprotected left main coronary artery disease insights from the ISAR-LEFT MAIN and ISAR-LEFT MAIN 2 trials.
Cassese S; Kufner S; Xhepa E; Byrne RA; Kreutzer J; Ibrahim T; Tiroch K; Valgimigli M; Tölg R; Fusaro M; Schunkert H; Laugwitz KL; Mehilli J; Kastrati A
Clin Res Cardiol; 2016 Jul; 105(7):575-84. PubMed ID: 26689707
[TBL] [Abstract][Full Text] [Related]
11. Comparison of bioresorbable vs durable polymer drug-eluting stents in unprotected left main (from the RAIN-CARDIOGROUP VII Study).
Iannaccone M; Barbero U; De Benedictis M; Imori Y; Quadri G; Trabattoni D; Ryan N; Venuti G; Montabone A; Wojakowski W; Rognoni A; Helft G; Parma R; De Luca L; Autelli M; Boccuzzi G; Mattesini A; Templin C; Cerrato E; Wańha W; Smolka G; Huczek Z; Tomassini F; Cortese B; Capodanno D; Chieffo A; Nuñez-Gil I; Gili S; Bassignana A; di Mario C; Doronzo B; Omedè P; D'Amico M; Tedeschi D; Varbella F; Luscher T; Sheiban I; Escaned J; Rinaldi M; D'Ascenzo F
BMC Cardiovasc Disord; 2020 May; 20(1):225. PubMed ID: 32414330
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcome after percutaneous treatment of de novo coronary bifurcation lesions using first or second generation of drug-eluting stents.
Ferenc M; Buettner HJ; Gick M; Comberg T; Rothe J; Khoury F; Valina C; Toma A; Kuebler P; Riede F; Neumann FJ
Clin Res Cardiol; 2016 Mar; 105(3):230-8. PubMed ID: 26329585
[TBL] [Abstract][Full Text] [Related]
13. Comparative effectiveness of different contemporary drug-eluting stents in routine clinical practice: a multigroup propensity score analysis using data from the stent-specific, multicenter, prospective registries.
Kwon O; Kang SH; Lee JB; Ahn JM; Lee CH; Kang DY; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ;
Coron Artery Dis; 2019 Jun; 30(4):255-262. PubMed ID: 30883430
[TBL] [Abstract][Full Text] [Related]
14. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.
Tiroch K; Mehilli J; Byrne RA; Schulz S; Massberg S; Laugwitz KL; Vorpahl M; Seyfarth M; Kastrati A;
JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416
[TBL] [Abstract][Full Text] [Related]
15. Two-year clinical outcomes of patients with overlapping second-generation drug-eluting stents for treatment of long coronary artery lesions: comparison of everolimus-eluting stents with resolute zotarolimus-eluting stents.
Li XT; Sun H; Zhang DP; Xu L; Ni ZH; Xia K; Liu Y; Chi YH; He JF; Li WM; Wang HS; Wang LF; Yang XC
Coron Artery Dis; 2014 Aug; 25(5):405-11. PubMed ID: 24584031
[TBL] [Abstract][Full Text] [Related]
16. Long-term clinical impact of polymer-free sirolimus-eluting stents in unselected patients.
Sinha N; Rai H; Cassese S; Kumar S; Kapoor A; Kastrati A
Coron Artery Dis; 2016 Aug; 27(5):385-90. PubMed ID: 27124380
[TBL] [Abstract][Full Text] [Related]
17. First generation versus second generation drug-eluting stents for the treatment of bifurcations: 5-year follow-up of the LEADERS all-comers randomized trial.
Grundeken MJ; Wykrzykowska JJ; Ishibashi Y; Garg S; de Vries T; Garcia-Garcia HM; Onuma Y; de Winter RJ; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Corti R; Wijns W; Morice MC; di Mario C; Meier B; Jüni P; Yazdani A; Copt S; Windecker S; Serruys PW
Catheter Cardiovasc Interv; 2016 Jun; 87(7):E248-60. PubMed ID: 26649651
[TBL] [Abstract][Full Text] [Related]
18. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.
Fujino Y; Attizzani GF; Bezerra HG; Wang W; Tahara S; Yamamoto H; Chamie D; Kanaya T; Mehanna E; Takagi K; Nakamura S; Costa MA
JACC Cardiovasc Interv; 2013 Oct; 6(10):1035-45. PubMed ID: 24156964
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Durable-Polymer Zotarolimus-Eluting and Biodegradable-Polymer Biolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: 3-Year Clinical Outcomes in the Randomized SORT OUT VI Trial.
Raungaard B; Christiansen EH; Bøtker HE; Hansen HS; Ravkilde J; Thuesen L; Aarøe J; Villadsen AB; Terkelsen CJ; Krusell LR; Maeng M; Kristensen SD; Veien KT; Hansen KN; Junker A; Madsen M; Andersen SL; Jensen SE; Jensen LO;
JACC Cardiovasc Interv; 2017 Feb; 10(3):255-264. PubMed ID: 28109874
[TBL] [Abstract][Full Text] [Related]
20. Safety and effectiveness of the self-aPposing, bAlloon-delivered, siRolimus-eluting stent for the Treatment of the coronary Artery disease: SPARTA, a multicenter experience.
Montefusco A; De Filippo O; Gili S; Mancone M; Calcagno S; Cirillo P; Esposito G; Poli A; Ferrara E; Smolka G; Wanha W; Palmieri C; Pastormerlo LE; Baumbach A; Sganzerla P; Tamburino C; Bruno F; Secco GG; Nicolino A; Yew KL; di Palma G; Wojakowski W; Sardella G; Rinaldi M; Cortese B; D'Ascenzo F
Coron Artery Dis; 2020 Jan; 31(1):27-34. PubMed ID: 31658146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
